Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

Mavrakis, Konstantinos J., McDonald, E. Robert, Schlabach, Michael R., Billy, Eric, Hoffman, Gregory R., deWeck, Antoine, Ruddy, David A., Venkatesan, Kavitha +36 more·2016·Science

DOI 10.1126/science.aad5944

Cited by (623)

Items 201–300 of 623

MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab
Jing Wang, Hui Zhu, Wenjuan Liu, Xiaoyang Zhai, Hairong Tian, Jinming Yu · 2020 · Scientific Reports
Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
Mohammad Alinoor Rahman, Farhana Nasrin, Sonali Bhattacharjee, Saikat Nandi · 2020 · Cancers
Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma
Bárbara Paranhos Coelho, Camila Felix de Lima Fernandes, Jacqueline Marcia Boccacino, Maria Clara da Silva Souza, Maria Isabel Melo-Escobar, Rodrigo Nunes Alves, Mariana Brandão Prado, Rebeca Piatniczka Iglesia, Giovanni Cangiano, Giulia La Rocca Mazzaro et al. · 2020 · Frontiers in Oncology
Characterization of Tumor-Suppressor Gene Inactivation Events in 33 Cancer Types
Peilin Jia, Zhongming Zhao · 2019 · Cell Reports
Early Clinical Success of MTA-Cooperative PRMT5 Inhibitors for the Treatment of CDKN2A/MTAP -Deleted Cancers
Kathleen M. Mulvaney · 2023 · Cancer Discovery
Synthetic lethality: a step forward for personalized medicine in cancer
Heena Jariyal, Frank D. Weinberg, Abhinav Achreja, Deepak Nagarath, Akshay Srivastava · 2019 · Drug Discovery Today
Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology
Martin Chevrier, Sara E. Monaco, Jacob A. Jerome, Françoise Galateau-Sallé, Andrew Churg, Sanja Đačić · 2020 · Cancer Cytopathology
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
Michael K.C. Lee, Sean Michael Grimmond, Grant A. McArthur, Karen E. Sheppard · 2021 · Cancers
Targeting the methionine addiction of cancer.
Joni C Sedillo, Vincent L. Cryns · 2022 · PubMed Central
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma
Shelby L. Sloan, Fiona Brown-Burke, Mackenzie Long, Christoph Weigel, Shirsha Koirala, Ji-Hyun Chung, Betsy A. Pray, Lynda Villagomez, Claire Hinterschied, Anuvrat Sircar et al. · 2023 · Blood
MTAP deficiency contributes to immune landscape remodelling and tumour evasion
Wen‐Hsin Chang, Ssu‐Wei Hsu, Jun Zhang, Ji‐Min Li, David C.H. Yang, Chih‐Wei Chu, Estelle Heerim Yoo, Weici Zhang, Sung‐Liang Yu, Ching‐Hsien Chen · 2022 · Immunology
Functions and mechanisms of non-histone post-translational modifications in cancer progression
Zongyang Li, Tao Zhu, Yushu Wu, Yongbo Yu, Yun-jiang Zang, Lebo Yu, Zhilei Zhang · 2025 · Cell Death Discovery
M-TAP Dance: Targeting PRMT1 and PRMT5 Family Members to Push Cancer Cells Over the Edge
Nivine Srour, Sofiane Yacine Mersaoui, Stéphane Richard · 2019 · Cancer Cell
Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression
Wei Liu, Congwen Zhuang, Tengfei Huang, Shengsheng Yang, Meiqing Zhang, Baoquan Lin, Yiguo Jiang · 2020 · Molecular Genetics & Genomic Medicine
Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities
Michael S. Lee, Shubham Pant · 2021 · American Society of Clinical Oncology Educational Book
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
Zachary A. Hing, Janek S. Walker, Ethan C. Whipp, Lindsey T. Brinton, Matthew J. Cannon, Pu Zhang, Steven Sher, Casey B. Cempre, Fiona Brown-Burke, Porsha L. Smith et al. · 2023 · Nature Communications
Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma
Christopher A. Febres‐Aldana, Jason C. Chang, Achim A. Jungbluth, Prasad S. Adusumilli, Francis M. Bodd, Denise Frosina, Jerica A. Geronimo, Enmily Hernandez, Helen Irawan, Michael David Offin et al. · 2024 · Modern Pathology
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, Guobo Shen, Xi Kuang · 2024 · MedComm – Oncology
Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery
Shuai‐Jiang Liu, Qian Zhao, Xiaochen Liu, Allan B. Gamble, Wei Huang, Qian‐Qian Yang, Bo Han · 2024 · Medicinal Research Reviews
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
Binbin Cheng, Xiaoting Fei, Zongbao Ding, Xiaopeng Peng, Zhenhong Su, Wei Pan, Jianjun Chen · 2024 · Journal of Medicinal Chemistry
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
James M. Smith, Bernard C. Barlaam, David Beattie, Lauren Bradshaw, Ho Man Chan, Elisabetta Chiarparin, Olga Collingwood, Sophie L. Cooke, Anna S. Cronin, Iain A. Cumming et al. · 2024 · Journal of Medicinal Chemistry
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors
Si Chen, Jiakai Hou, Roshni Jaffery, Ashley M. Guerrero, Rongjie Fu, Leilei Shi, Ningbo Zheng, Ritu Bohat, Nicholas A. Egan, Cheng‐Tai Yu et al. · 2024 · Journal for ImmunoTherapy of Cancer
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP -Deleted Cancers
Liping H. Pettus, Matthew P. Bourbeau, Nuria A. Tamayo, Albert K. Amegadzie, Diane Beylkin, Shon K. Booker, John Butler, Michael J. Frohn, Matthew R. Kaller, Todd J. Kohn et al. · 2025 · Journal of Medicinal Chemistry
Generating Stable Knockout Zebrafish Lines by Deleting Large Chromosomal Fragments Using Multiple gRNAs
Brian H Kim, Guangjun Zhang · 2020 · G3 Genes Genomes Genetics
Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors
Ernesto Guccione, Megan Catherine Schwarz, Federico Di Tullio, Slim Mzoughi · 2021 · Current Opinion in Pharmacology
Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer
Yong-Xing Du, Zong-Ting Gu, Zong-Ze Li, Zan Yuan, Yue Zhao, Xiao-Hao Zheng, Xiao-Chen Bo, He-Bing Chen, Cheng-Feng Wang · 2022 · Advancement of science
Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities
Rajita J. Vatapalli, Alex P. Rossi, Ho Man Chan, Jingwen Zhang · 2024 · Epigenomics
Identification of 5-benzylidene-2-phenylthiazolones as potent PRMT5 inhibitors by virtual screening, structural optimization and biological evaluations
Kongkai Zhu, Hongrui Tao, Jiali Song, Jin Lu, Yuanyuan Zhang, Jingqiu Liu, Zhifeng Chen, Cheng‐Shi Jiang, Cheng Luo, Hua Zhang · 2018 · Bioorganic Chemistry
Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer
Ying Zhang, Tiantian Zhang, Lin Gao, Yanan Tan, Yuting Li, Xiangyu Tan, Tuxiong Huang, Huahui Li, Feng Bai, Chang Zou et al. · 2022 · International Journal of Biological Sciences
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
Shinsuke Araki, Momoko Ohori, Masato Yugami · 2023 · Frontiers in Oncology
Cofactors As Metabolic Sensors Driving Cell Adaptation in Physiology and Disease
Nabil Rabhi, Sarah Anissa Hannou, Philippe Froguel, Jean‐Sébastien Annicotte · 2017 · Frontiers in Endocrinology
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor
Alessandra Feoli, Giulia Iannelli, Alessandra Cipriano, Ciro Milite, Lei Shen, Zhihao Wang, Andrea Hadjikyriacou, Troy L. Lowe, Cyrus Safaeipour, Monica Viviano et al. · 2023 · Journal of Medicinal Chemistry
A review of the known MTA-cooperative PRMT5 inhibitors
Mei Long Hu, Xiang Chen · 2024 · RSC Advances
SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells
Xiaotian Wang, Yongsheng Song, Yaxing Shi, Da Cheng Yang, Jiaxing Li, Bo Yin · 2022 · Cellular & Molecular Biology Letters
Paradoxical Increase of Permeability and Lipophilicity with the Increasing Topological Polar Surface Area within a Series of PRMT5 Inhibitors
Upendra A. Argikar, Markus Blatter, Dallas Bednarczyk, Zhuoliang Chen, Young Shin Cho, Michaël Doré, Jennifer L. Dumouchel, Samuel B. Ho, Klemens Hoegenauer, Toshio Kawanami et al. · 2022 · Journal of Medicinal Chemistry
Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer
Xiao Li, Fei Li, Fei Ye, Haotian Guo, Wentao Chen, Jia Jin, Yiran Wang, Pengfei Dai, Huili Shi, Hongru Tao et al. · 2023 · Cell Reports
Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5′-Methylthioadenosine Phosphorylase
Ross Firestone, Scott A. Cameron, Jerome M. Karp, Vickery L. Arcus, Vern L. Schramm · 2016 · ACS Chemical Biology
Targeting the insulin-like growth factor-1 receptor in MTAP-deficient renal cell carcinoma
Jihao Xu, Wen‐Hsin Chang, Lon Wolf R. Fong, Robert H. Weiss, Sung‐Liang Yu, Ching‐Hsien Chen · 2019 · Signal Transduction and Targeted Therapy
PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells
Matthew S. Gillespie, Kelly Chiang, Gemma L. Regan-Mochrie, Soo‐Youn Choi, Ciara M. Ward, Debashish Sahay, Paloma García, Roland R. Arnold, Clare C. Davies · 2024 · Oncogene
SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO
Patrícia Cristine Borck, Isabella Boyle, Kristina Janković, Nolan R. Bick, Kyla J. Foster, Anthony C. Lau, Lucy Parker-Burns, Daniel A. Lubicki, Tianxia Li, Ashir A. Borah et al. · 2025 · Nature
Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma
Haoran Mu, Qi Zhang, Dongqing Zuo, Jinzeng Wang, Yining Tao, Zhen Li, Xin He, Huanliang Meng, Hongsheng Wang, Jiakang Shen et al. · 2025 · Cell Reports Medicine
Synthetic lethality in cancer drug discovery: challenges and opportunities
Emanuel Gonçalves, Colm J. Ryan, David J. Adams · 2025 · Nature Reviews Drug Discovery
The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
Bénédikt Jacobs, Sebastian Schlögl, Carolin Dorothea Strobl, Simon Völkl, Andrej Stoll, Dimitrios Mougiakakos, Karl‐Johan Malmberg, Andréas Mackensen, Michael Aigner · 2020 · Frontiers in Immunology
Keep a watchful eye on methionine adenosyltransferases, novel therapeutic opportunities for hepatobiliary and pancreatic tumours
Peiwen Yang, Juying Jiao, Zhen Chen, Xiaoyan Zhu, Chien‐shan Cheng · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Cryo-electron microscopy structure of a human PRMT5:MEP50 complex
David E. Timm, Valorie D. Bowman, Russell E. Madsen, Charles T. Rauch · 2018 · PLoS ONE
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
Verónica Rendo, Ivaylo Stoimenov, André Mateus, Elin Sjöberg, Richard Svensson, Anna‐Lena Gustavsson, Lars Johansson, Adrian Ng, Casey O’Brien, Marios Giannakis et al. · 2020 · Nature Communications
MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer
Fadi E. Pulous, Barbara Steurer, Frank W. Pun, Man Zhang, Feng Ren, Alex A. Zhavoronkov · 2024 · Drug Discovery Today
From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy
Ian Sarvary, M. Vestergaard, Loris Moretti, Jan Andersson, Jorge Peiró Cadahía, Sanne Cowland, Thomas Flagstad, Thomas Franch, Alex Haahr Gouliaev, Gitte Husemoen et al. · 2025 · Journal of Medicinal Chemistry
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode
Vineet Pande, Weimei Sun, Lijs Beke, Didier Berthelot, Dirk Brehmer, David Brown, Jordi Corbera, Steve Irving, Lieven Meerpoel, Thomas Nys et al. · 2020 · ACS Medicinal Chemistry Letters
Glioblastoma and Methionine Addiction
Mark L. Sowers, Lawrence C. Sowers · 2022 · International Journal of Molecular Sciences
Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma
Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu, Gaomeng Wei, Jiaqi Su, Xi Tian, Jing Xia, Yuanyuan Qu, Jian‐Yuan Zhao, Hailiang Zhang et al. · 2022 · Frontiers in Immunology
Is There a Therapeutic Window for Metabolism-Based Cancer Therapies?
Sarah‐Maria Fendt · 2017 · Frontiers in Endocrinology
The Transition-State Structure for Human MAT2A from Isotope Effects
Ross Firestone, Vern L. Schramm · 2017 · Journal of the American Chemical Society
Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations
Kongkai Zhu, Cheng‐Shi Jiang, Hongrui Tao, Jingqiu Liu, Hua Zhang, Cheng Luo · 2018 · Bioorganic & Medicinal Chemistry Letters
The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription
Zhiwen Fan, Xiaocen Kong, Jun Xia, Xiaoyan Wu, He Li, Huihui Xu, Mingming Fang, Yong Xu · 2016 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction
Jacob M. Winter, Heidi L. Fresenius, Corey Nathaniel Cunningham, Peng Wei, Heather R. Keys, Jordan A. Berg, Alex J. Bott, Tarun Yadav, Jeremy A. Ryan, Deepika Sirohi et al. · 2022 · eLife
Protein arginine methyltransferase 5–mediated arginine methylation stabilizes Kruppel-like factor 4 to accelerate neointimal formation
He Liu, Xiaoliang Dong, Kunpeng Jia, Baohui Yuan, Zhengnan Ren, Xiaohua Pan, Jianjin Wu, Jiahong Li, Jingwen Zhou, Ruxing Wang et al. · 2023 · Cardiovascular Research
PRMT5-mediated FUBP1 methylation accelerates prostate cancer progression
Weiwei Yan, Xun Liu, Xuefeng Qiu, Xuebin Zhang, Jiahui Chen, Kai Xiao, Ping Wu, Chao Peng, Xiaolin Hu, Zengming Wang et al. · 2024 · Journal of Clinical Investigation
Epigenetic Regulation of Fanconi Anemia Genes Implicates PRMT5 Blockage as a Strategy for Tumor Chemosensitization
Changzheng Du, Steven W. Li, Simranjit X. Singh, Kristen Roso, Michael A. Sun, Christopher J. Pirozzi, Rui Yang, Jian-Liang Li, Yiping He · 2021 · Molecular Cancer Research
Deletion ofMTAPHighly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase
YUSUKE AOKI, Yasunori Tome, Qinghong Han, Jun Yamamoto, Kazuyuki Hamada, NORIYUKI MASAKI, Yutaro Kubota, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman · 2022 · Cancer Genomics & Proteomics
Alterations of Histone Modifications in Cancer
Amir Hosseini, Saverio Minucci · 2018 · Elsevier eBooks
Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response
Geny Piro, Antonio Agostini, Alberto Larghi, Giuseppe Quero, Carmine Carbone, Annachiara Esposito, Gianenrico Rizzatti, Fabia Attili, Sergio Alfieri, Guido Costamagna et al. · 2021 · Frontiers in Medicine
Fragment optimization and elaboration strategies – the discovery of two lead series of PRMT5/MTA inhibitors from five fragment hits
Christopher R. Smith, Svitlana Kulyk, Misbha Ud Din Ahmad, Valentina Arkhipova, James G. Christensen, Robin J. Gunn, Anthony Ivetac, John M. Ketcham, Jon E. Kuehler, J. David Lawson et al. · 2022 · RSC Medicinal Chemistry
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment
Christopher A. Febres‐Aldana, Rachel E. Fanaroff, Michael David Offin, Marjorie Glass Zauderer, Jennifer L. Sauter, Soo‐Ryum Yang, Marc Ladanyi · 2023 · Annual Review of Pathology Mechanisms of Disease
Metabolome profiling by widely-targeted metabolomics and biomarker panel selection using machine-learning for patients in different stages of chronic kidney disease
Yao-Hua Gu, Yu Chen, Qing Li, Neng‐Bin Xie, Xue Xing, Jun Xiong, Min Shan Hu, Tian-Zhou Li, Ke-Yu Yuan, Yu Liu et al. · 2024 · Chinese Chemical Letters
Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough
Di Wu, Shengqiang Yang, Chenyang Yuan, Kejia Zhang, Jiachen Tan, Kaifeng Guan, Hong Zeng, Chunjie Huang · 2024 · International Journal of Biological Macromolecules
Copy Number Alterations in Enzyme-Coding and Cancer-Causing Genes Reprogram Tumor Metabolism
Ashwini Kumar Sharma, Roland Eils, Rainer König · 2016 · Cancer Research
Synthetic lethality: emerging targets and opportunities in melanoma
Nicola Thompson, David J. Adams, Marco Ranzani · 2017 · Pigment Cell & Melanoma Research
Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase
Rajesh K. Harijan, Oskar Hoff, Rodrigo Gay Ducati, Ross Firestone, Brett M. Hirsch, Gary B. Evans, Vern L. Schramm, Peter C. Tyler · 2019 · Journal of Medicinal Chemistry
Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells
Yan Tang, Souheil El‐Chemaly, Angelo M. Taveira‐DaSilva, Hilary J. Goldberg, Shefali Bagwe, Iván O. Rosas, Joel Moss, Carmen Priolo, Elizabeth P. Henske · 2019 · CHEST Journal
Protein arginine methylation in transcription and epigenetic regulation
Hoang Quoc Hai Pham, Xiaoqun Tao, Yanzhong Yang · 2023 · Frontiers in Epigenetics and Epigenomics
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers
M.M. Gounder, Patricia Martín-Romano, Antoîne Italiano, L. L. Siu, Philippe Alexandre Cassier, Gerald Steven Falchook, Izidore S. Lossos, Drew Warren Rasco, J.F. Hilton, Meredith Ann McKean et al. · 2025 · Annals of Oncology
Magnetic-Driven Hydrogel Microrobots Selectively Enhance Synthetic Lethality in MTAP-Deleted Osteosarcoma
Haoran Mu, Chenlu Liu, Qi Zhang, Huanliang Meng, Shimin Yu, Ke Zeng, Jing Han, Xinmeng Jin, Shi Shi, Peiyao Yu et al. · 2022 · Frontiers in Bioengineering and Biotechnology
An update on small molecule compounds targeting synthetic lethality for cancer therapy
Jiaxiang Luo, Yang Li, Yiwen Zhang, Defa Wu, Yijiu Ren, Jie Liu, Chengdi Wang, Jifa Zhang · 2024 · European Journal of Medicinal Chemistry
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer
Verónica Rendo, Michaël Schubert, Nicholas Khuu, Maria F. Suárez Peredo Rodríguez, Declan Whyte, Xiao Ling, Anouk van den Brink, Kaimeng Huang, Michelle L. Swift, Yizhou Joseph He et al. · 2025 · Nature Communications
In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer
Jon Pey, Edurne San José‐Eneriz, María Carmen Ochoa, Iñigo Apaolaza, Pedro de Atauri, Ángel Rubio, Xabier Cendoya, Estíbaliz Miranda, Leire Gárate, Marta Cascante et al. · 2017 · Scientific Reports
The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
Tanner Wright, Yalong Wang, Mark T. Bedford · 2021 · Epigenomes
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors
Christopher R. Smith, Ruth Aranda, James G. Christensen, Lars D. Engstrom, Robin J. Gunn, Anthony Ivetac, John M. Ketcham, Jon E. Kuehler, J. David Lawson, Matthew A. Marx et al. · 2022 · Bioorganic & Medicinal Chemistry
The Rio1 protein kinases/ATPases: conserved regulators of growth, division, and genomic stability
Giovanna Berto, Sébastien Ferreira-Cerca, Peter De Wulf · 2018 · Current Genetics
Interferon Epsilon Loss Is Elusive 9p21 Link to Immune-Cold Tumors, Resistant to Immune Checkpoint Therapy, and Endogenous CXCL9/10 Induction
Xin Zhao, Bin Liu, William N. William, Kaloyan M. Tsanov, Yu-Jui Ho, Francisco M. Barriga, Raymond J. Lim, Maria Trifas, Azhar Khandekar, Yushen Du et al. · 2024 · Journal of Thoracic Oncology
Nutrient control of splice site selection contributes to methionine addiction of cancer
Dawei Lin, Francisco Carranza, Stacey L. Borrego, Linda Lauinger, Lucas Dantas de Paula, Harika Reddy Pulipelli, Anna Andronicos, Klemens J. Hertel, Peter Kaiser · 2025 · Molecular Metabolism
Load and lock: An emerging class of therapeutics that influence macromolecular dissociation
Raymond J. Deshaies, Patrick Ryan Potts · 2025 · Science
Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway
Katey L. Witham, Rodney F. Minchin, Neville J. Butcher · 2016 · Biochemical Pharmacology
Mechanism and Inhibition of Human Methionine Adenosyltransferase 2A
Courtney N. Niland, Agnidipta Ghosh, Sean M. Cahill, Vern L. Schramm · 2021 · Biochemistry
Scalable Atroposelective Synthesis of MRTX1719: An Inhibitor of the PRMT5/MTA Complex
Michał Achmatowicz, Thomas Scattolin, David R. Snead, Dinesh J. Paymode, Sahar Roshandel, Chen Xie, Guihui Chen, Cheng‐yi Chen · 2023 · Organic Process Research & Development
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2
Jessica M. Posada, Evgeny Yakirevich, Ashish M. Kamat, Akshay Sood, Joseph M Jacob, Gennady Bratslavsky, Petros D. Grivas, Philippe E. Spiess, Roger Li, Andrea Necchi et al. · 2024 · Modern Pathology
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers
Gianluca Mauri, Giorgio Patelli, Laura Roazzi, Emanuele Valtorta, Alessio Amatu, Giovanna Marrapese, Erica Francesca Bonazzina, Federica Tosi, Katia Bruna Bencardino, Gabriele Ciarlo et al. · 2024 · Journal of Clinical Pathology
Development of a Series of Pyrrolopyridone MAT2A Inhibitors
Stephen J. Atkinson, Sharan K. Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Elisabetta Chiarparin, Muireann Coen, Iain T. Collie, Ian L. Dale, Claudia De Fusco et al. · 2024 · Journal of Medicinal Chemistry
Loss of MTAP Expression by Immunohistochemistry Is a Surrogate Marker for Homozygous 9p21.3 Deletion in Urothelial Carcinoma
Tatjana Vlajnic, Obinna Chijioke, Luca Roma, Spasenija Savic Prince, Tobias Zellweger, Cyrill A. Rentsch, Lukas Bubendorf · 2024 · Modern Pathology
Nucleotide Metabolism Behind Epigenetics
Tamaki Suganuma, Jerry L. Workman · 2021 · Frontiers in Endocrinology
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study
Andrea Necchi, Philippe E. Spiess, Marco Bandini, Giuseppe Basile, Petros D. Grivas, Gennady Bratslavsky, Joseph M Jacob, Natalie A. Danziger, Douglas I. Lin, Brennan James Decker et al. · 2022 · The Oncologist
Identification of Selective, Cell Active Inhibitors of Protein Arginine Methyltransferase 5 through Structure-Based Virtual Screening and Biological Assays
Fei Ye, Weiyao Zhang, Xiaoqing Ye, Jia Jin, Zhengbing Lv, Cheng Luo · 2018 · Journal of Chemical Information and Modeling
Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential
Chi Ma, Aoshuang Xu, Liping Zuo, Qun Li, Fengjuan Fan, Yu Hu, Chunyan Sun · 2025 · Pharmaceuticals
Cracking PRMT5: Mechanistic insights, clinical advances, and AI-driven strategies
Faranak Alipourgivi, Jing Su, Tao Lu · 2025 · Cancer Letters
SCISSOR: a framework for identifying structural changes in RNA transcripts
Hyo Young Choi, Heejoon Jo, Xiaobei Zhao, Katherine A. Hoadley, Scott Newman, Jeremiah Ray Holt, Michele C. Hayward, Michael I. Love, James Stephen Marron, David Neil Hayes · 2021 · Nature Communications
Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP‐deficient lung cancer
Wen‐Hsin Chang, Yi‐Ju Chen, Yi‐Jing Hsiao, Ching-Cheng Chiang, Chia‐Yu Wang, Ya‐Ling Chang, Qi‐Sheng Hong, Shr‐Uen Lin, Shr‐Uen Lin, Gee‐Chen Chang et al. · 2022 · EMBO Reports
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science
Darrin D. Stuart, Angel Guzman-Perez, Natasja Brooijmans, Erica L. Jackson, Gregory V. Kryukov, Adam A. Friedman, Axel Hoos · 2023 · Cancer Discovery
Medicinal chemistry insights into PRMT5 inhibitors
Zhihao Jiao, Yongmi Huang, Kexin Gong, Yiru Liu, Jinxiao Sun, Shangzhe Yu, Guisen Zhao · 2024 · Bioorganic Chemistry
MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design
Kevin M. Cottrell, Douglas A. Whittington, Kimberly J. Briggs, Haris Jahić, Janid A. Ali, Alvaro J. Amor, Deepali Gotur, Matthew R. Tonini, Wenhai Zhang, Alan Huang et al. · 2025 · Journal of Medicinal Chemistry
Protein arginine methyltransferases and hepatocellular carcinoma: A review
Lei Yu, Ping Han, Dean Tian · 2021 · Translational Oncology